Oxytocin Receptor Antagonist Therapy In The Luteal Phase For Implantation And Pregnancy In Women Undergoing Assisted Reproductive Technologies
Patent No. EP3501533 (titled "Oxytocin Receptor Antagonist Therapy In The Luteal Phase For Implantation And Pregnancy In Women Undergoing Assisted Reproductive Technologies") was filed by Ferring on Dec 22, 2014. The application was issued on Jul 9, 2025.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3501533
- Application Number
- EP19153560A
- Filing Date
- Dec 22, 2014
- Status
- Granted And Under Opposition
- Jun 6, 2025
- Publication Date
- Jul 9, 2025
- External Links
- Slate, Register , Google Patents